EA202192133A1 - Моногидрат гидрохлорида рогаратиниба и его твердые состояния - Google Patents
Моногидрат гидрохлорида рогаратиниба и его твердые состоянияInfo
- Publication number
- EA202192133A1 EA202192133A1 EA202192133A EA202192133A EA202192133A1 EA 202192133 A1 EA202192133 A1 EA 202192133A1 EA 202192133 A EA202192133 A EA 202192133A EA 202192133 A EA202192133 A EA 202192133A EA 202192133 A1 EA202192133 A1 EA 202192133A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- rogaratinib
- hydrochloride monohydrate
- solid states
- methyl
- monohydrate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Abstract
Кристаллическая форма [4-{[4-амино-6-(метоксиметил)-5-(7-метокси-5-метил-1-бензотиофен-2-ил)пирроло[2,1-f][1,2,4]триазин-7-ил]метил}пиперазин-2-он-гидрохлорида] формулы (III)которая представляет собой моногидрат, способ ее получения, содержащие ее фармацевтические композиции и ее применения для контроля нарушений.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19154781 | 2019-01-31 | ||
PCT/EP2020/051884 WO2020156982A1 (en) | 2019-01-31 | 2020-01-27 | The monohydrate of rogaratinib hydrochloride and solid states thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202192133A1 true EA202192133A1 (ru) | 2022-02-09 |
Family
ID=65276007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202192133A EA202192133A1 (ru) | 2019-01-31 | 2020-01-27 | Моногидрат гидрохлорида рогаратиниба и его твердые состояния |
Country Status (21)
Country | Link |
---|---|
US (1) | US20220098201A1 (ru) |
EP (1) | EP3917929A1 (ru) |
JP (1) | JP2022519081A (ru) |
KR (1) | KR20210119994A (ru) |
CN (1) | CN113382997A (ru) |
AU (1) | AU2020214188A1 (ru) |
BR (1) | BR112021012876A2 (ru) |
CA (1) | CA3128073A1 (ru) |
CL (1) | CL2021001977A1 (ru) |
CO (1) | CO2021009660A2 (ru) |
DO (1) | DOP2021000162A (ru) |
EA (1) | EA202192133A1 (ru) |
EC (1) | ECSP21056314A (ru) |
GE (1) | GEP20237531B (ru) |
IL (1) | IL284927A (ru) |
JO (1) | JOP20210204A1 (ru) |
MA (1) | MA54856A (ru) |
MX (1) | MX2021009173A (ru) |
SG (1) | SG11202107919YA (ru) |
TW (1) | TW202035413A (ru) |
WO (1) | WO2020156982A1 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107864625B (zh) * | 2015-03-09 | 2021-05-28 | 拜耳制药股份公司 | 含有取代的2,3-二氢咪唑并[1,2-c]喹唑啉的组合产品 |
CN113720956B (zh) * | 2021-09-08 | 2022-03-29 | 广州国标检验检测有限公司 | 一种气质联用检测药物中硫酸酯的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2385053B1 (en) * | 2005-11-17 | 2013-10-02 | OSI Pharmaceuticals, Inc. | Intermediates for the preparation of fused bicyclic mTOR inhibitors |
PE20070855A1 (es) | 2005-12-02 | 2007-10-14 | Bayer Pharmaceuticals Corp | Derivados de 4-amino-pirrolotriazina sustituida como inhibidores de quinasas |
ES2545907T3 (es) * | 2005-12-29 | 2015-09-16 | Abbvie Inc. | Inhibidores de proteína quinasa |
UY34484A (es) | 2011-12-15 | 2013-07-31 | Bayer Ip Gmbh | Benzotienilo-pirrolotriazinas disustituidas y sus usos |
-
2020
- 2020-01-27 CN CN202080011813.4A patent/CN113382997A/zh active Pending
- 2020-01-27 MA MA054856A patent/MA54856A/fr unknown
- 2020-01-27 KR KR1020217024012A patent/KR20210119994A/ko unknown
- 2020-01-27 US US17/310,347 patent/US20220098201A1/en active Pending
- 2020-01-27 CA CA3128073A patent/CA3128073A1/en active Pending
- 2020-01-27 JP JP2021544610A patent/JP2022519081A/ja active Pending
- 2020-01-27 EA EA202192133A patent/EA202192133A1/ru unknown
- 2020-01-27 JO JOP/2021/0204A patent/JOP20210204A1/ar unknown
- 2020-01-27 AU AU2020214188A patent/AU2020214188A1/en not_active Abandoned
- 2020-01-27 WO PCT/EP2020/051884 patent/WO2020156982A1/en active Application Filing
- 2020-01-27 EP EP20702012.4A patent/EP3917929A1/en not_active Withdrawn
- 2020-01-27 MX MX2021009173A patent/MX2021009173A/es unknown
- 2020-01-27 SG SG11202107919YA patent/SG11202107919YA/en unknown
- 2020-01-27 GE GEAP202015724A patent/GEP20237531B/en unknown
- 2020-01-27 BR BR112021012876-0A patent/BR112021012876A2/pt unknown
- 2020-01-31 TW TW109103030A patent/TW202035413A/zh unknown
-
2021
- 2021-07-18 IL IL284927A patent/IL284927A/en unknown
- 2021-07-23 CO CONC2021/0009660A patent/CO2021009660A2/es unknown
- 2021-07-27 CL CL2021001977A patent/CL2021001977A1/es unknown
- 2021-07-29 EC ECSENADI202156314A patent/ECSP21056314A/es unknown
- 2021-07-30 DO DO2021000162A patent/DOP2021000162A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN113382997A (zh) | 2021-09-10 |
JP2022519081A (ja) | 2022-03-18 |
US20220098201A1 (en) | 2022-03-31 |
IL284927A (en) | 2021-09-30 |
CA3128073A1 (en) | 2020-08-06 |
DOP2021000162A (es) | 2021-09-15 |
JOP20210204A1 (ar) | 2023-01-30 |
ECSP21056314A (es) | 2021-08-31 |
EP3917929A1 (en) | 2021-12-08 |
BR112021012876A2 (pt) | 2021-09-08 |
CO2021009660A2 (es) | 2021-08-09 |
MX2021009173A (es) | 2021-09-10 |
CL2021001977A1 (es) | 2022-02-25 |
SG11202107919YA (en) | 2021-08-30 |
TW202035413A (zh) | 2020-10-01 |
AU2020214188A1 (en) | 2021-07-15 |
GEP20237531B (en) | 2023-08-25 |
MA54856A (fr) | 2022-05-04 |
WO2020156982A1 (en) | 2020-08-06 |
KR20210119994A (ko) | 2021-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020500125A1 (en) | 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof | |
WO2020140005A8 (en) | 1h-pyrrolo[2,3-b]pyridine derivatives and related compounds as bcl-2 inhibitors for the treatment of neoplastic and autoimmune diseases | |
PH12021550045A1 (en) | 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof | |
GEP20217242B (en) | Pyrazolo[1,5-a]pyrazin-4-yl derivatives as jak-inhibitors | |
MX2021015605A (es) | Compuestos 2,3-dihidroquinazolin como inhibidores nav1.8. | |
SA518391518B1 (ar) | مشتقات n-] 2-(1- بنزيل ببريدين-4-يل) إيثيل[ -4-(بيرازين-2-يل)-ببرازين-1- كربوكساميد ومركبات متصلة بها كمضادات مستقبلة المسكارين 4 (m4) لمعالجة أمراض عصبية | |
MX2020010675A (es) | Derivados de pirazolo-triazina y/o pirazolo-pirimidina como inhibidor selectivo de cinasa dependiente de ciclina. | |
SI3106463T1 (en) | Compounds of substituted pyrazolo (1,5-) pyrimidine as inhibitors of TRK kinase | |
EA202091475A1 (ru) | ПРОИЗВОДНЫЕ 5-(2-(2,5-ДИФТОРФЕНИЛ)ПИРРОЛИДИН-1-ИЛ)-3-(1H-ПИРАЗОЛ-1-ИЛ)ПИРАЗОЛО[1,5-а]ПИРИМИДИНА И РОДСТВЕННЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ Trk КИНАЗЫ ДЛЯ ЛЕЧЕНИЯ РАКА | |
EA200400289A1 (ru) | Производные аминоизоксазола, активные в качестве ингибиторов киназы | |
EA202192019A1 (ru) | Производные 3-(1-оксо-5-(пиперидин-4-ил)изоиндолин-2-ил)пиперидин-2,6-диона и пути их применения | |
PH12021551117A1 (en) | 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-one derivatives as hpk1 inhibitors for the treatment of cancer | |
EA202192133A1 (ru) | Моногидрат гидрохлорида рогаратиниба и его твердые состояния | |
EA202091016A1 (ru) | Пиримидиновое соединение в качестве ингибитора jak киназы | |
EA202191801A1 (ru) | Гетероциклические ингибиторы mat2a и способы применения для лечения рака | |
MX2020010563A (es) | Derivados de pirazolo-triazina y/o pirazolo-pirimidina farmaceuticamente activos. | |
SA519401322B1 (ar) | مركبات أريل كربوكساميد غير متجانسة كمثطبات لكيناز بروتين سيرين/ ثريونين متداخل مع المستقبل 2 | |
WO2014106800A8 (en) | Substituted 2-amino pyrimidine derivatives as kinase inhibitors | |
BR112012020557A2 (pt) | formas cristalinas de sódio 4- {[9-cloro-7-(2-flúor-6-metoifenil)-5h-pirimido [5,4-d] [2] benzazepin-2-il]-amino}-2 metoxibenzoato de sódio. | |
MX2023006842A (es) | Proceso de fabricacion e intermediarios para un compuesto de pirrolo[2,3-d]pirimidina y su uso. | |
EA202190323A1 (ru) | ИМИДАЗО[1,2-b]ПИРИДАЗИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ Trk | |
JOP20210275A1 (ar) | مشتقات 3-أمينو-4h-بنزو[e][4,2,1]ثيادايازين 1,1-داي أكسيد كمثبطات لـ mrgx2 | |
EA201992744A1 (ru) | Фармацевтические композиции n-(2-(2-(диметиламино)этокси)-4-метокси-5-((4-(1-метил-1h-индол-3-ил)пиримидин-2-ил)амино)фенил)акриламида и его солей | |
MX2022005951A (es) | Compuestos de pirrolotriazina que actuan como inhibidor de mnk. | |
BR112018075823A2 (pt) | sais farmacêuticos de n-(2-(2-(dimetilamino)etoxi)-4-metoxi-5-((4-(1-metil-1h-indol-3-il)pirimidin-2-il)amino)fenil)acrilamida e suas formas cristalinas |